Christine J. Saoud

Array ( [id] => 7217149 [patent_doc_number] => 20040071787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Pharmacologic, therapeutic and diagnostic regulation of FGF-1 export' [patent_app_type] => new [patent_app_number] => 10/383860 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 36195 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071787.pdf [firstpage_image] =>[orig_patent_app_number] => 10383860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797809 [patent_doc_number] => 20030176683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Cartilage-derived morphogenetic proteins' [patent_app_type] => new [patent_app_number] => 10/379830 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9596 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176683.pdf [firstpage_image] =>[orig_patent_app_number] => 10379830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740541 [patent_doc_number] => 08106009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Pharmaceutical composition for preventing or treating ischemic diseases' [patent_app_type] => utility [patent_app_number] => 10/371030 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8400 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106009.pdf [firstpage_image] =>[orig_patent_app_number] => 10371030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428680 [patent_doc_number] => 07268114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Protein and process for preparing the same' [patent_app_type] => utility [patent_app_number] => 10/365231 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 23 [patent_no_of_words] => 5668 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268114.pdf [firstpage_image] =>[orig_patent_app_number] => 10365231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769491 [patent_doc_number] => 20030215431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Management of mucosal viscosity by TFF monomer peptides' [patent_app_type] => new [patent_app_number] => 10/364751 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7756 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215431.pdf [firstpage_image] =>[orig_patent_app_number] => 10364751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788101 [patent_doc_number] => 20030139340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI)' [patent_app_type] => new [patent_app_number] => 10/270479 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14943 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139340.pdf [firstpage_image] =>[orig_patent_app_number] => 10270479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 202673 [patent_doc_number] => 07632808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system' [patent_app_type] => utility [patent_app_number] => 10/356513 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8666 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632808.pdf [firstpage_image] =>[orig_patent_app_number] => 10356513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 558673 [patent_doc_number] => 07470665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Methods for targeting cells that express fibroblast growth receptor-3 or -2' [patent_app_type] => utility [patent_app_number] => 10/354859 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21344 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470665.pdf [firstpage_image] =>[orig_patent_app_number] => 10354859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362603 [patent_doc_number] => 20040005314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Apo-2l receptor agonist and cpt-11 synergism' [patent_app_type] => new [patent_app_number] => 10/333712 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29129 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005314.pdf [firstpage_image] =>[orig_patent_app_number] => 10333712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829832 [patent_doc_number] => 20030180890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Novel FGF homolog ZFGF12' [patent_app_type] => new [patent_app_number] => 10/347505 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21424 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180890.pdf [firstpage_image] =>[orig_patent_app_number] => 10347505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333253 [patent_doc_number] => 20040131613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'TNF-alpha binding molecules' [patent_app_type] => new [patent_app_number] => 10/338627 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25868 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131613.pdf [firstpage_image] =>[orig_patent_app_number] => 10338627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6834662 [patent_doc_number] => 20030162208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Cloned leptospira outer membrane protein' [patent_app_type] => new [patent_app_number] => 10/322391 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8920 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162208.pdf [firstpage_image] =>[orig_patent_app_number] => 10322391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478044 [patent_doc_number] => 07223564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Four-helical bundle protein zsig81' [patent_app_type] => utility [patent_app_number] => 10/315379 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 35173 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223564.pdf [firstpage_image] =>[orig_patent_app_number] => 10315379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843608 [patent_doc_number] => 20030148955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Soluble tumor necrosis factor receptor treatment of medical disorders' [patent_app_type] => new [patent_app_number] => 10/314618 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13122 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148955.pdf [firstpage_image] =>[orig_patent_app_number] => 10314618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6808701 [patent_doc_number] => 20030198640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta' [patent_app_type] => new [patent_app_number] => 10/310793 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 131583 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198640.pdf [firstpage_image] =>[orig_patent_app_number] => 10310793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702104 [patent_doc_number] => 20030224984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis' [patent_app_type] => new [patent_app_number] => 10/305654 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 393 [patent_figures_cnt] => 393 [patent_no_of_words] => 71046 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224984.pdf [firstpage_image] =>[orig_patent_app_number] => 10305654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840147 [patent_doc_number] => 07390491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Agents comprising midkine or an inhibitor thereof as active ingredient' [patent_app_type] => utility [patent_app_number] => 10/298889 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4863 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390491.pdf [firstpage_image] =>[orig_patent_app_number] => 10298889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159345 [patent_doc_number] => 07674769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)' [patent_app_type] => utility [patent_app_number] => 10/270478 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10666 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674769.pdf [firstpage_image] =>[orig_patent_app_number] => 10270478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729565 [patent_doc_number] => 20030185755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Novel ectoparasite saliva proteins and apparatus to collect such proteins' [patent_app_type] => new [patent_app_number] => 10/271344 [patent_app_country] => US [patent_app_date] => 2002-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 44518 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185755.pdf [firstpage_image] =>[orig_patent_app_number] => 10271344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870047 [patent_doc_number] => 20030082736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Fusion proteins comprising tumor necrosis factor receptor' [patent_app_type] => new [patent_app_number] => 10/252408 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20690 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082736.pdf [firstpage_image] =>[orig_patent_app_number] => 10252408 [rel_patent_id] =>[rel_patent_doc_number] =>)